Gunderson Dettmer has advised Tarsus Pharmaceuticals. Latham & Watkins has advised Alkeus Pharmaceuticals. Tarsus Pharmaceuticals (Nasdaq: TARS) has entered into a definitive agreement to acquire Alkeus...
Tarsus Pharmaceuticals Signs Agreement to Acquire Alkeus Pharmaceuticals
Eli Lilly Acquires AtaiBeckley to Expand Mental Health Treatment Pipeline in $3.8 Billion Deal
Ropes & Gray has advised Eli Lilly and Company. Latham & Watkins has advised AtaiBeckley Inc. Eli Lilly and Company (NYSE: LLY) has entered into a...
atai Life Sciences Merges with Beckley Psytech
NautaDutilh and Latham & Watkins advised atai Life Sciences, while Debevoise & Plimpton advised Guggenheim Securities as financial advisor to atai Life Sciences. atai Life Sciences...
Carlyle and SK Capital’s Acquisition of bluebird bio
Wachtell, Lipton, Rosen & Katz, Kirkland & Ellis, and Orrick, Herrington & Sutcliffe are serving as legal advisors to Carlyle and SK Capital, while Latham &...
Seres Therapeutics’ VOWST Asset Purchase Agreement With Nestlé Health Science
Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
Danaher’s US$ 5.7 Billion Acquisition of Abcam Plc
Latham & Watkins advises on Abcam’s US$5.7 billion sale to Danaher. Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a global science and technology innovator, announced...
Amgen’s $3.7 Billion Acquisition of ChemoCentryx
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
Ligand’s Spin-off of OmniAb Business
Latham & Watkins represented Ligand in the transaction, while Weil, Gotshal & Manges represented APAC. Ligand Pharmaceuticals Incorporated has announced the signing of a definitive merger...
UCB’s Acquisition of Zogenix
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
P3 Health Partners’ Business Combination with Foresight Acquisition Corp.
Latham & Watkins represented P3 Health Partners in the transaction. P3 Health Partners, a patient-centered and physician-led population health management company, has closed its previously announced business combination...
Waldencast’s $1.2 Billion Business Combination With Obagi and Milk Makeup
Skadden, Arps, Slate, Meagher & Flom represented Waldencast. Latham & Watkins, working alongside Conyers and Nixon Peabody, represented Obagi, and Goodwin Procter represented Milk Makeup in...